Noah Lechtzin

7.6k citations
130 papers · 6.1k · 2 hit papers · h-index 43

Impact in

    • Cystic Fibrosis Research Advances
    • Pulmonary Hypertension Research and Treatments
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Respiratory Support and Mechanisms
  • Neurology top 2%
    • Amyotrophic Lateral Sclerosis Research

Papers in

    • Cystic Fibrosis Research Advances 40
    • Pulmonary Hypertension Research and Treatments 12
    • Lung Cancer Diagnosis and Treatment 9
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
    • Respiratory Support and Mechanisms 6
    • Inhalation and Respiratory Drug Delivery 4
    • Amyotrophic Lateral Sclerosis Research 23

Noah Lechtzin

126 papers receiving 5.9k citations

Noah Lechtzin's Hit Papers

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study 2023 · 109 citations
1090+2+5Years since publication100200300

Peers

Noah Lechtzin
Comparison fields: 5 of 156
  • Pulmonary and Respiratory Medicine 3.1k
  • Neurology 674
  • Genetics 474
  • Molecular Medicine 181
  • Pathology and Forensic Medicine 464
Replace Ron Wolterbeek with:
Ron Wolterbeek Netherlands
Geert M. Verleden Belgium
Pascale Fabbro-Péray France
Lieven Dupont Belgium
Sang-Won Lee South Korea
Hee Young Shin South Korea
Michael S. Schechter United States
Duncan M Geddes United Kingdom
Kameshwar Prasad India
Heini Huhtala Finland
Noah Lechtzin relative to Ron Wolterbeek Netherlands Ron Wolterbeek's profile →
Citations per field
00.5×2×3×4.3×
Ron Wolterbeek · 1×
Citations per year

Countries citing papers authored by Noah Lechtzin

Since Specialization
Citations

This map shows the geographic impact of Noah Lechtzin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noah Lechtzin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noah Lechtzin more than expected).

Fields of papers citing papers by Noah Lechtzin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noah Lechtzin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noah Lechtzin. The network helps show where Noah Lechtzin may publish in the future.

Co-authors

The 25 scholars most cited alongside Noah Lechtzin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Noah Lechtzin Line = papers co-authored together Noah Lechtzin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003345
2
Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections
Hit paper breakdown →
2018310
3 2008278
4 2003225
5 2010198
6 1998176
7 2011168
8 2012167
9 2002148
10 2015135
11 2007134
12 2009119
13 2006118
14 2011109
15
Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study
Hit paper breakdown →
2023109
16 2009108
17 2005107
18 2017105
19 2010100
20 2013100

About Noah Lechtzin

Noah Lechtzin is a scholar working on Pulmonary and Respiratory Medicine, Neurology, Genetics, Epidemiology and Infectious Diseases, having authored 130 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (40 papers), Amyotrophic Lateral Sclerosis Research (23 papers), Neurogenetic and Muscular Disorders Research (15 papers), Pulmonary Hypertension Research and Treatments (12 papers), Lung Cancer Diagnosis and Treatment (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Respiratory Support and Mechanisms (6 papers) and Inhalation and Respiratory Drug Delivery (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.1k citations), Neurology (674 citations), Genetics (474 citations), Molecular Medicine (181 citations) and Pathology and Forensic Medicine (464 citations). Noah Lechtzin has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Gregory B. Diette, Michael Boyle, Lora Clawson, Christian A. Merlo, Charles M. Wiener, Reda E. Girgis, Haya R. Rubin, Paul M. Hassoun, Stephen C. Mathai and Edward F. Haponik. Their work appears in journals such as Journal of Cystic Fibrosis, CHEST Journal, American Journal of Respiratory and Critical Care Medicine, Annals of the American Thoracic Society and Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact